| Primary |
| Hypersensitivity |
16.3% |
| Drug Use For Unknown Indication |
15.4% |
| Product Used For Unknown Indication |
13.1% |
| Rhinitis Allergic |
12.7% |
| Sinusitis |
6.6% |
| Nasal Congestion |
5.4% |
| Rhinitis |
5.4% |
| Seasonal Allergy |
5.0% |
| Multiple Allergies |
4.7% |
| Sinus Disorder |
3.4% |
| Asthma |
2.2% |
| Nasal Polyps |
2.2% |
| Nasopharyngitis |
1.5% |
| Sinus Congestion |
1.3% |
| Chronic Sinusitis |
1.0% |
| Influenza |
0.9% |
| Upper-airway Cough Syndrome |
0.9% |
| Prophylaxis |
0.8% |
| Rhinitis Seasonal |
0.7% |
| Rhinorrhoea |
0.7% |
|
| Product Quality Issue |
46.2% |
| Anosmia |
5.2% |
| Cataract |
4.9% |
| Epistaxis |
4.6% |
| Drug Ineffective |
4.4% |
| Underdose |
3.7% |
| No Adverse Event |
3.5% |
| Death |
3.4% |
| Glaucoma |
3.2% |
| Headache |
2.8% |
| Product Container Issue |
2.6% |
| Vomiting |
2.3% |
| Rhinorrhoea |
2.0% |
| Vision Blurred |
1.8% |
| Nasal Discomfort |
1.7% |
| Intraocular Pressure Increased |
1.6% |
| Nasal Congestion |
1.6% |
| Throat Irritation |
1.6% |
| Insomnia |
1.5% |
| Visual Impairment |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
19.3% |
| Asthma |
11.5% |
| Hypersensitivity |
9.9% |
| Drug Use For Unknown Indication |
9.5% |
| Foetal Exposure During Pregnancy |
6.9% |
| Sinusitis |
5.6% |
| Rhinitis Allergic |
5.3% |
| Nasal Congestion |
3.9% |
| Multiple Allergies |
3.7% |
| Seasonal Allergy |
3.6% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Rhinitis |
2.8% |
| Nasopharyngitis |
2.7% |
| Hypertension |
2.2% |
| Bronchitis |
1.8% |
| Depression |
1.8% |
| Pain |
1.8% |
| Upper Limb Fracture |
1.8% |
| Suicide Attempt |
1.6% |
| Blood Cholesterol Increased |
1.5% |
|
| Product Quality Issue |
18.9% |
| Drug Ineffective |
10.8% |
| Throat Irritation |
6.1% |
| Vision Blurred |
6.1% |
| Osteonecrosis |
5.4% |
| Epistaxis |
4.7% |
| Myalgia |
4.7% |
| Visual Acuity Reduced |
4.7% |
| Ventricular Septal Defect |
4.1% |
| Weight Increased |
4.1% |
| Sleep Disorder |
3.4% |
| Tendon Rupture |
3.4% |
| Vitreous Floaters |
3.4% |
| Vomiting |
3.4% |
| Weight Decreased |
3.4% |
| Cataract |
2.7% |
| Dyspnoea |
2.7% |
| Heart Rate Increased |
2.7% |
| Loss Of Consciousness |
2.7% |
| Palatal Disorder |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
17.6% |
| Asthma |
11.9% |
| Hypersensitivity |
5.5% |
| Hypertension |
4.7% |
| Pain |
4.3% |
| Depression |
3.0% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Multiple Allergies |
2.2% |
| Anxiety |
2.1% |
| Osteoporosis |
1.9% |
| Diabetes Mellitus |
1.7% |
| Seasonal Allergy |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Sinusitis |
1.5% |
| Contraception |
1.4% |
| Rhinitis Allergic |
1.2% |
| Prophylaxis |
1.2% |
|
| Vomiting |
11.6% |
| Weight Decreased |
7.9% |
| Weight Increased |
7.7% |
| Wheezing |
7.5% |
| Pulmonary Embolism |
5.6% |
| Drug Ineffective |
5.2% |
| Dyspnoea |
4.9% |
| Pain |
4.8% |
| Sinusitis |
4.4% |
| Pneumonia |
4.1% |
| Headache |
4.0% |
| Nausea |
4.0% |
| Suicidal Ideation |
3.8% |
| Urticaria |
3.7% |
| Vision Blurred |
3.7% |
| Death |
3.6% |
| Product Quality Issue |
3.5% |
| Rash |
3.5% |
| Urinary Tract Infection |
3.3% |
| Pain In Extremity |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Blood Cholesterol Increased |
13.3% |
| Blood Pressure |
13.3% |
| Gastrooesophageal Reflux Disease |
10.0% |
| Hiv Infection |
6.7% |
| Bipolar Disorder |
3.3% |
| Contraception |
3.3% |
| Convulsion |
3.3% |
| Grand Mal Convulsion |
3.3% |
| Hiv Test Positive |
3.3% |
| Sinusitis |
3.3% |
| Thyroid Disorder |
3.3% |
|
| Myalgia |
44.4% |
| Anxiety |
11.1% |
| Cushing's Syndrome |
11.1% |
| Drug Ineffective |
11.1% |
| Grand Mal Convulsion |
11.1% |
| Weight Decreased |
11.1% |
|
